Business Context and Reporting Period
Company: enVVeno Medical Corporation (NVNO)
Filing Type: Form 8-K (Current Report)
Date of Report: July 14, 2026
Reporting Period: Single event date (July 14, 2026)
Business Context: The Company is a Delaware corporation headquartered in Irvine, California, with common stock traded on The NASDAQ Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of an investor presentation rather than a financial statement.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The primary event reported is the issuance of an investor presentation on July 14, 2026.
Guidance, Outlook, and Management Commentary
- Item 7.01 (Regulation FD Disclosure): The Company issued an investor presentation on July 14, 2026, which may be used in meetings with investors and analysts.
- Exhibit 99.1: The full investor presentation is attached as Exhibit 99.1 and incorporated by reference.
- Legal Disclaimer: The information in this report and the attached exhibit is not deemed "filed" under Section 18 of the Exchange Act and will not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor Presentation) for specific financial guidance, operational updates, and strategic outlook not included in the 8-K text.
- Verify the trading status of common stock (Symbol: NVNO) on The NASDAQ Stock Market LLC.
- Confirm the identity of the authorized signatory, Robert A. Berman, Chief Executive Officer.
- Note that this filing does not contain audited financial data; refer to the most recent 10-K or 10-Q for historical financial metrics.